| || 225245BR |
| || Director, Patient Advocacy - US Oncology |
| || ONCOLOGY |
| || ONCOLOGY |
| || USA |
| || East Hanover, NJ |
| || Novartis Pharmaceuticals |
| || Communications & Public Affairs |
| || Oncology |
| || Full Time |
| || Regular |
| || Job Purpose:
The Director will establish productive and enduring relationships with Oncology-focused patient advocacy groups aligned with NPC therapeutic areas of interest. This individual will collaborate with key internal/external stakeholders sharing knowledge and insights with an emphasis on policy, access and unmet patient needs.
1. Establishes, builds and strengthens relationships with non-tumor specific oncology Patient Advocacy groups (i.e American Cancer Society, Cancer Support Community, Friends of Cancer Research, Cancer Care, Patient Advocate Foundation, NORD, Global Genes) and selected disease groups within the rare disease community.
2. Develops a broad network of personal contacts with general cancer advocacy groups and leads relationship building and activities of mutual interest with these stakeholders. Utilize these relationships, as needed, to facilitate discussions on access to innovative treatments and quality patient care in cancer. Identify areas of common interest for the company and work to ensure Novartis leadership position in oncology to the external community.
3. Develops and implements strategic patient advocacy plans and activities by collaborating with Novartis teams to include; medical, brands/franchises, legal, compliance, HEOR, digital, communications/PR, health policy, federal affairs, and access teams.
4. Represent Novartis at key advocacy organization meeting and events. Works to ensure Novartis leadership position in oncology to the external community.
5. Portfolio lead with enterprise view to help drive department strategy, implement new processes, ensure consistency and best practice sharing.
6. Lead cross divisional strategy with Sandoz and state/federal policy teams to support Novartis OBU and reputational objectives.
7. Play key role in bring patient voice to the OBU; leverage patient insights across functions to inform programming.
8. Oversees grant and sponsorship process for general cancer, policy and rare disease groups; actively works with patient advocacy groups on the submission and approval process.
9. Compliance lead for team (i.e. monitoring WPDs, training, work plans). Ensures compliance with internal policies and external regulations in all program planning and execution.
10. Ensures key activities are implemented in a timely manner and that activities are prioritized in line with strategic focus of Novartis and the organization. Ensures “metrics” are maintained.
| || The Novartis Group of Companies are Equal Opportunity Employers and take pride in maintaining a diverse environment. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. |
| || Education:
• Bachelor degree is required. Advanced degree preferred.
• 8+ years patient advocacy or advocacy relations experience required from a healthcare company or related organization.
• Experience in oncology preferred
• Proven ability to work effectively in a cross functional environment.
• Demonstrated ability to build relationships with patient advocacy groups, professional associations and other stakeholders
• Strong project and process management skills, with the ability to work under tight time constraints and manage multiple projects simultaneously
• Confident personal presence and experience managing and hosting live activities/programs
• Excellent communication and presentation skills
• Ability and skill to work effectively with executive management and other leadership teams
• Demonstrated success working in a matrix environment with diverse groups/function, overseeing complex programs and teams
• Strategic and results oriented
• Comfortable with ambiguity
• Results-driven and exercises exceptional judgment
• Ability to travel approx. 30%